Dose-Seeking Study of MPT0E028 in Subjects With Advanced Solid Malignancies Without Standard Treatment
Status:
Completed
Trial end date:
2019-01-19
Target enrollment:
Participant gender:
Summary
The Dose Escalation Phase will determine the MTD of MPT0E028 and evaluate its safety and
tolerability, PK, PD, and preliminary clinical effects; the subsequent Dose Confirmation
Phase will be a cohort expansion at or below the MTD (i.e., an RP2D) of MPT0E028.